Streetbeat News

Analyst Ratings

ZS

Piper Sandler analyst Rob Owens maintains an Overweight rating on Zscaler but lowers the price target from $255 to $215.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:38 pm

BBIO

Piper Sandler has initiated coverage on BridgeBio Pharma with an Overweight rating and set a price target of $46.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:37 pm

ATHA

BTIG analyst Thomas Shrader has downgraded Athira Pharma from Buy to Neutral, indicating a change in the analyst's outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:36 pm

LI

Citigroup analyst Jeff Chung has downgraded Li Auto (NASDAQ:LI) from Buy to Neutral, indicating a change in the investment outlook for the company.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:33 pm

TWFG

Keefe, Bruyette & Woods has maintained a Market Perform rating on TWFG and raised its price target from $27 to $28.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:32 pm

STC

Keefe, Bruyette & Woods has maintained a Market Perform rating on Stewart Information Services (NYSE:STC) and raised the price target from $71 to $75.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:31 pm

LEN

Keefe, Bruyette & Woods has maintained an 'Outperform' rating on Lennar (NYSE:LEN) and raised its price target from $183 to $230, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:30 pm

FNF

Keefe, Bruyette & Woods has maintained a Market Perform rating on Fidelity National Financial (NYSE:FNF) and raised the price target from $58 to $63.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:28 pm

FAF

Keefe, Bruyette & Woods has maintained an 'Outperform' rating on First American Financial (NYSE:FAF) and raised the price target from $66 to $72.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:27 pm

BHVN

Bernstein analyst William Pickering has initiated coverage on Biohaven (NYSE:BHVN) with an Outperform rating and set a price target of $55.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:25 pm